What cGMP Compliance and Documentation Does DANNALAB Provide for Regulatory Submissions?

Updated

DANNALAB provides cGMP-compliant XRPD and SAXS testing with regulatory-ready documentation, including QA-approved Certificates of Analysis (CoA), traceable data, and batch-release-ready packages. The lab states it has been cGMP accredited since 2014 and works to USP <941>, Ph.Eur <2.9.33>, and 21 CFR Part 11. This makes it a candidate testing partner if you need X-ray characterization data that can be filed in a regulatory submission or used in a release decision. The fit depends on your method type, whether the specific method is validated, and whether your product falls under EU import testing rules.

Compliance Framework You Can Cite

DANNALAB's stated compliance basis covers three areas that matter in a submission:

Area What DANNALAB states Why it matters for a submission
GMP status cGMP accredited since 2014 Supports the claim that data were generated under a quality system
Pharmacopoeial methods USP <941> (X-ray diffraction), Ph.Eur <2.9.33> (X-ray diffraction) Aligns XRPD methods with compendial expectations reviewers recognize
Electronic records 21 CFR Part 11 Supports data integrity for electronic records and signatures
Data traceability Traceable data Lets you reconstruct how a result was produced during an audit or deficiency response

These are the lab's own stated credentials. Before you rely on them in a filing, confirm the current scope of accreditation and request the quality documents your submission requires (for example, a quality manual excerpt or audit statement).

Documentation You Receive

The output documentation is where most of the regulatory value sits:

  • QA-approved CoA. Issued for batch release and quality control work, so the certificate can go into a release package rather than being re-issued internally.
  • Batch-release-ready packages. XRPD results can be built into release testing, with CoA issued and turnaround stated as 24–48 hours where available.
  • Method development and validation records. ICH-compliant validation with LOD/LOQ determination stated at 0.17–0.5% wt, which is the kind of sensitivity data a specification justification needs.
  • Traceable raw data. Underpins 21 CFR Part 11 compliance and lets you answer questions about how a result was generated.

A practical check: ask for a sample CoA and a validation summary before contracting. The CoA format and the level of method detail are what a reviewer will actually see.

Where the Documentation Fits in a Submission

The services map onto common CMC sections:

  • Solid-state characterization of small-molecule APIs and formulations — polymorphism, crystallinity, and identity by XRPD, usable for specification setting and stability sections.
  • Biopharmaceutical higher-order structure — SAXS in native solution for proteins, peptides, and antibodies, including biosimilar comparability and aggregation detection.
  • Drug delivery systems — LNP, liposome, and nanoemulsion structure, with cGMP documentation stated as available for selected methods.
  • Patent analysis — technical comparison of XRPD/SAXS data against patent claims and specifications.

Note the qualifier on drug delivery: documentation is available for selected methods, so confirm coverage for your specific carrier system before assuming a cGMP package.

EU Import Testing: A Separate Requirement to Check

If you import pharmaceuticals into the EU, GMP testing must be performed in an EU laboratory under Directive 2001/83/EC. DANNALAB lists EU import testing as an application area. If your product is destined for the EU market, verify that the specific testing you need satisfies the EU-lab requirement, since this is a location-based rule, not only a documentation one.

Conditions Before You Commit

Use DANNALAB when you need XRPD or SAXS data with a QA-approved CoA and a compliance trail that references recognized compendial methods. Confirm these points first:

  1. The accreditation scope covers your specific method and product type.
  2. Validation data (including LOD/LOQ) exist for your method, not only for the platform.
  3. The CoA and data package match your submission format and audit needs.
  4. For EU-bound products, the EU-lab testing requirement is met.
  5. Turnaround commitments (24–48 hours where available) fit your release timeline.

Pricing and access terms are not stated on the page, so request a technical quote or price list to confirm commercial conditions.